Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV; Announcement of Hearing

Özet

This is notice that the Drug Enforcement Administration (DEA) will hold a hearing with respect to the proposed placement of carisoprodol in schedule IV of the Controlled Substances Act (21 U.S.C. 801, et seq.). The control of carisoprodol was initially proposed in a Notice of Proposed Rulemaking published in the Federal Register on November 17, 2009 [74 FR 59108].